Naor Nir — SEC Form 4 filings

SEC reporting owner CIK 1982278. 4 Form 4 filings on record with FilingPulse; latest filed 2026-07-23.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-01-03 to 2026-07-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)Director22
Axogen, Inc. (AXGN)CFO11
Neuronetics, Inc. (STIM)EVP, CFO & Treasurer11

Form 4 filings — Naor Nir

FiledFormIssuerReported transactionsSource
2026-07-234Neuronetics, Inc. (STIM)Grant/award (A): 500,000 @ $0EDGAR
2026-05-204BRAINSTORM CELL THERAPEUTICS INC. (BCLI)Grant/award (A): 180,000 (derivative) @ $0.70EDGAR
2025-01-064Axogen, Inc. (AXGN)Tax withholding (F): 39,132 @ $15.22EDGAR
2025-01-034BRAINSTORM CELL THERAPEUTICS INC. (BCLI)Grant/award (A): 30,666 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1982278 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →